×
For best experience we recommend to activate Javascript in your browser.
Ephrin B1 antibody (AA 31-165)
This anti-Ephrin B1 antibody is a Rabbit Polyclonal antibody detecting Ephrin B1 in WB, ELISA and IHC. Suitable for Mouse.
Quick Overview for Ephrin B1 antibody (AA 31-165) (ABIN7569163)
Target
See all Ephrin B1 (EFNB1) Antibodies
Ephrin B1 (EFNB1)
Reactivity
All reactivities for Ephrin B1 antibodies
Mouse
Host
All hosts for Ephrin B1 antibodies
Rabbit
Clonality
All clonalities for Ephrin B1 antibodies
Polyclonal
Conjugate
All conjugates for Ephrin B1 antibodies
This Ephrin B1 antibody is un-conjugated
Application
All applications for Ephrin B1 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-Ephrin B1 Antibody
(hide)
Binding Specificity
All epitopes for Ephrin B1 antibodies
AA 31-165
Purpose
Anti-Mouse EFNB1 Polyclonal Antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Mouse EFNB1 (Asn31-Gly165).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for Ephrin B1
(hide)
Target
Ephrin B1 (EFNB1)
Alternative Name
EFNB1
Background
Ephrin-B1 (CEK5 receptor ligand) (CEK5-L) (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2) (Stimulated by retinoic acid gene 1 protein) [Cleaved into: Ephrin-B1 C-terminal fragment (Ephrin-B1 CTF), Ephrin-B1 intracellular domain (Ephrin-B1 ICD)]
UniProt
P52795
Pathways
RTK Signaling
Recently viewed
(hide)
Chat with us , powered by LiveChat